[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100625324":3},{"organization":4,"outcomesModule":7,"designInfo":18,"detailedDescription":25,"studyPopulation":17,"armGroups":26,"interventions":33,"overallOfficials":37,"centralContacts":41,"locations":49,"responsibleParty":74,"collaborators":77,"id":81,"slug":17,"hasResults":82,"nctId":83,"briefTitle":84,"officialTitle":85,"acronym":17,"eligibilityCriteria":86,"healthyVolunteers":82,"sex":87,"minAge":88,"maxAge":17,"enrollmentInfo":89,"targetDuration":17,"studyType":92,"phases":93,"briefSummary":94,"conditions":95,"keywords":97,"overallStatus":99,"whyStopped":17,"lastUpdateSubmitDate":100,"lastUpdatePostDateStruct":101,"startDateStruct":104,"completionDateStruct":106,"leadSponsor":108,"locationsCount":109},{"fullName":5,"class":6},"University of Pennsylvania","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":17},[9],{"measure":10,"description":11,"timeFrame":12},"Adherence","% from baseline to active phase that patient adheres to using needle disposal","Days 1-180",[14],{"measure":15,"description":15,"timeFrame":16},"Patient and provider satisfaction survey","Day 181 +\u002F- 7 days",null,{"allocation":19,"interventionModel":20,"interventionModelDescription":21,"primaryPurpose":22,"observationalModel":17,"timePerspective":17,"maskingInfo":23},"NA","SINGLE_GROUP","Everyone gets a Sharps needle disposal device.","SUPPORTIVE_CARE",{"masking":24,"maskingDescription":17,"whoMasked":17},"NONE","Preventative factor or non-factor product IV administration has been shown to improve outcomes in patients with hemophilia. The need for patients to log their doses or complete questionnaires can be burdensome. This study seeks to use novel technology, a smart sharps container that records disposal of the needle used to administer preventive products. We will perform a prospective study of adult patients with hemophilia A\u002FB who are on factor or non-factor products. They will all be given the device to take home and use there.",[27],{"label":28,"type":29,"description":30,"interventionNames":31},"intervention of being given device to use","EXPERIMENTAL","needle disposal device",[32],"Other: The smart Sharps device is given to the patient and they use it to throw needles away in. It is not internal to the patient.",[34],{"type":6,"name":35,"description":35,"armGroupLabels":36,"otherNames":17},"The smart Sharps device is given to the patient and they use it to throw needles away in. It is not internal to the patient.",[28],[38],{"name":39,"affiliation":5,"role":40},"Allyson Pishko, MD","PRINCIPAL_INVESTIGATOR",[42,46],{"name":39,"role":43,"phone":44,"phoneExt":17,"email":45},"CONTACT","215-615-6555","Allyson.Pishko@pennmedicine.upenn.edu",{"name":47,"role":43,"phone":44,"phoneExt":17,"email":48},"Karen Panckeri, MBE","Karen.Panckeri@pennmedicine.upenn.edu",[50,68],{"facility":51,"status":17,"city":52,"state":53,"zip":54,"country":55,"countryCode":56,"cosmosGeoPoint":57,"geoPoint":62,"contacts":63},"Hospital of the University of Pennsylvania","Philadelphia","Pennsylvania","19104","United States","US",{"type":58,"coordinates":59},"Point",[60,61],-75.16362,39.95238,{"lat":61,"lon":60},[64,66,67],{"name":65,"role":43,"phone":44,"phoneExt":17,"email":45},"Primary Investigator",{"name":47,"role":43,"phone":44,"phoneExt":17,"email":48},{"name":39,"role":40,"phone":17,"phoneExt":17,"email":17},{"facility":69,"status":17,"city":52,"state":53,"zip":70,"country":55,"countryCode":56,"cosmosGeoPoint":71,"geoPoint":73,"contacts":17},"Penn Blood Disorders Program","19130-3805",{"type":58,"coordinates":72},[60,61],{"lat":61,"lon":60},{"type":40,"investigatorFullName":75,"investigatorTitle":76,"investigatorAffiliation":5,"oldNameTitle":17,"oldOrganization":17},"Allyson Pishko","Assistant Professor",[78],{"name":79,"class":80},"Sharpscue","UNKNOWN","100625324",false,"NCT07421154","Study of a Smart Sharps Disposal Device in Patients With Hemophilia","Study of a Smart Sharps Disposal in Patients With Hemophilia","Inclusion:\n\n* Male or female, ≥18 years of age\n* Moderate or Severe Hemophilia A or B, with or without an inhibitor\n* Prescribed prophylaxis with either a factor product or emicizumab that is scheduled to be given at least once every 14 days\n\nExclusion:\n\n* Stated inability to use the SharpsCue container\n* Treatment with another investigational drug or other intervention during the study period\n* Patients on prophylactic dosing less than once every 14 days\n* Patients who are infused by a home nurse","ALL","18 Years",{"count":90,"type":91},23,"ESTIMATED","INTERVENTIONAL",[19],"This pilot study will have patients use a smart sharps disposal container at home for disposal of needles used to administer their hemophilia drugs. The study aims to find out if the smart sharps container proved acceptable to use by patients and medical providers and can be adhered to.",[96],"Hemophilia A and B",[98],"hemophilia","NOT_YET_RECRUITING","2026-04-21",{"date":102,"type":103},"2026-04-23","ACTUAL",{"date":105,"type":91},"2026-05-01",{"date":107,"type":91},"2027-01-30",{"name":5,"class":6},2]